SCHEMBL27384652

SCHEMBL27384652

CCc1cc2[nH]c(CNC(=O)N3CCCC3)cc2cc1Cl

nearest known ligand 0.41

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 1/20 0.41
▸ MAPK1 P28482 1/20 0.38
▸ EPHX2 P34913 12/20 0.38
▸ RAB9A P51151 1/20 0.38
▸ CYP2C9 P11712 3/20 0.37
▸ CYP2J2 P51589 3/20 0.37
▸ GRIN2D O15399 1/20 0.37
▸ GRIN3B O60391 1/20 0.37
▸ GRIN1 Q05586 1/20 0.37
▸ GRIN2A Q12879 1/20 0.37
▸ GRIN2B Q13224 1/20 0.37
▸ GRIN2C Q14957 1/20 0.37
▸ GRIN3A Q8TCU5 1/20 0.37
▸ HRH3 Q9Y5N1 1/20 0.37
▸ HTT P42858 1/20 0.36
▸ L3MBTL1 Q9Y468 1/20 0.36
▸ CYP2C19 P33261 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27384658 0.90 HTT (0.46) SMN1; SMN2MAPK1EPHX2HRH3HTT
SCHEMBL27384356 0.86 SMN1; SMN2 (0.40) SMN1; SMN2MAPK1EPHX2RAB9ACYP2C9
SCHEMBL27384661 0.85 EPHX2 (0.39) SMN1; SMN2EPHX2RAB9ACYP2C9CYP2J2
SCHEMBL27384649 0.85 HTT (0.42) SMN1; SMN2MAPK1EPHX2RAB9ACYP2C9
SCHEMBL27384854 0.84 MAPK1 (0.41) SMN1; SMN2MAPK1EPHX2RAB9AGRIN2B
SCHEMBL27382489 0.81 SMN1; SMN2 (0.47) SMN1; SMN2RAB9AGRIN2DGRIN3BGRIN1
SCHEMBL27382554 0.80 MTNR1A (0.46) SMN1; SMN2MAPK1RAB9ACYP2C9GRIN2D
SCHEMBL30946075 0.80 MAPK1 (0.34) SMN1; SMN2MAPK1EPHX2CYP2C9CYP2J2
SCHEMBL30946079 0.80 EPHX2 (0.35) MAPK1EPHX2CYP2C9CYP2J2GRIN2B
SCHEMBL27383138 0.79 SMN1; SMN2 (0.45) SMN1; SMN2MAPK1RAB9AGRIN2DGRIN3B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024081748-A2 INHIBITORS OF SOLUTE CARRIER FAMILY 6A MEMBER 19 (SLC6A19) AND METHODS OF USE THEREOF MAZE THERAPEUTICS, INC. (US) 2024-04-18 — — WO disclosed
Send feedback